Actively Recruiting
Intravenous Hydromorphone for the Treatment of Acute Pain
Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2025-11-17
30
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
T
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Lead Sponsor
Y
Yichang Humanwell Pharmaceutical Co., Ltd., China
Collaborating Sponsor
AI-Summary
What this Trial Is About
To observe the efficacy and safety of hydromorphone in the treatment of acute chest pain, and to explore the potential advantages of hydromorphone for analgesia in patients with acute chest pain, so as to provide more theoretical basis for individualized analgesia and rapid recovery in patients with acute chest pain.
CONDITIONS
Official Title
Intravenous Hydromorphone for the Treatment of Acute Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-64 years old
- Any gender
- Acute chest pain with time from pain onset to doctor visit less than or equal to 24 hours
- Severe pain requiring opioid use as determined by emergency physicians
- Informed consent obtained from patient or family members
You will not qualify if you...
- Known allergy to hydromorphone or morphine
- Systolic blood pressure less than 100 mmHg
- Oxygen saturation less than 95%
- Pulse rate less than 60 beats per minute
- Use of acetaminophen or nonsteroidal anti-inflammatory drugs within the past 8 hours
- Chronic pain lasting more than 12 weeks
- Delirium, alcohol withdrawal symptoms, or other drug intoxication
- Pregnant or lactating women
- Mental or neurological diseases, cognitive or consciousness disorders preventing correct expression
- Participation in another research study at the same time
- Life-threatening chest pain requiring rapid diagnosis or treatment interventions such as resuscitation, or chest pain caused by myocardial infarction
- Other factors increasing risk of study participation as judged by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China, 210008
Actively Recruiting
Research Team
H
Hao Sun, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here